Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.

Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 3665, Suchdauer: 1.31s

12 3 4 5 6 7 8 9 10 11 weiter »

1
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19

von Glascock, Abigail ; Maguire, Cole ; Phan, Hoang Van ; et al.

Nature Microbiology. 11(4):1100-1112
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

2
Circulating endothelial signatures correlate with worse outcomes in COVID-19, respiratory failure and ARDS

von Costa Monteiro, Ana C. ; Pickering, Harry ; Sarma, Aartik ; et al.

Critical Care. 29(1)
- Zum Volltext in PubMed Central
Merkliste

3
Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients

von Pickering, Harry ; Schaenman, Joanna ; Phan, Hoang Van ; et al.

Nature Communications. 16(1)
- Zum Volltext in PubMed Central
Merkliste

4
Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohort

von Naresh Doni Jayavelu, PhD ; Jingjing Qi, MSc ; Carly E. Milliren, MPH ; et al.

Journal of Allergy and Clinical Immunology: Global, Vol 4, Iss 4, Pp 100515- (2025)

Schlagworte: Asthma; SARS-CoV-2; IMPACC; Immunologic diseases. Allergy; RC581-607
- View full text via DOI
Merkliste

5
Author Correction: Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors

von Doni Jayavelu, Naresh ; Samaha, Hady ; Wimalasena, Sonia Tandon ; et al.

Communications Medicine. 6(1)
- Zum Volltext in PubMed Central
Merkliste

6
Optimizing lower intensity triplet therapy in acute myeloid leukemia: a practical guide

von Wei-Ying Jen ; Curtis A. Lachowiez ; Jennifer Marvin-Peek ; et al.

Blood Cancer Journal, Vol 16, Iss 1, Pp 1-11 (2025)

Schlagworte: Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

7
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors

von Doni Jayavelu, Naresh ; Samaha, Hady ; Wimalasena, Sonia Tandon ; et al.

Communications Medicine. 6(1)
- Zum Volltext in PubMed Central
Merkliste

8
A phase 1/2 study of DS-1594 menin inhibitor in relapsed/refractory acute leukemias

von Jayastu Senapati ; Marina Konopleva ; Ghayas C. Issa ; et al.

Journal of Hematology & Oncology, Vol 18, Iss 1, Pp 1-12 (2025)

Schlagworte: Acute myeloid leukemia; Menin inhibitor; KMT2A; NPM1; Differentiation syndrome; Diseases of the blood and blood-forming organs; RC633-647.5; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

9
Case Report: FIA plus venetoclax in a patient on hemodialysis

von Jacob E. Herstein ; Kayleigh R. Marx ; J. Michael Savoy ; et al.

Frontiers in Oncology, Vol 15 (2026)

Schlagworte: acute myeloid leukemia; case report; chemotherapy; hematologic oncology; hemodialysis; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

10
VEN in combination with 10-day DEC in newly diagnosed elderly or relapsed/refractory acute myeloid leukemia, and high-risk myelodysplastic syndrome: long term follow-up of a phase 2 trial

von Mahesh Swaminathan ; Courtney D. DiNardo ; Abhishek Maiti ; et al.

Blood Cancer Journal, Vol 15, Iss 1, Pp 1-4 (2025)

Schlagworte: Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

11
Long-term outcomes in FLT3-mutated acute myeloid leukemia after frontline hypomethylating agent, venetoclax and a FLT3 inhibitor

von Nicholas J. Short ; Sanam Loghavi ; Musa Yilmaz ; et al.

Haematologica, Vol 999, Iss 1 (2025)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

12
Impact of measurable residual disease clearance kinetics in patients with AML undergoing intensive chemotherapy

von Wei-Ying Jen ; Koji Sasaki ; Farhad Ravandi ; et al.

Blood Advances, Vol 9, Iss 4, Pp 783-792 (2025)

Schlagworte: Specialties of internal medicine; RC581-951
- View full text via DOI
Merkliste

13

Dieses Ergebnis aus CINAHL kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.

Merkliste

14
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study

von Ozonoff, Al ; Schaenman, Joanna ; Jayavelu, Naresh Doni ; et al.

In eBioMedicine September 2022 83
- View full text via DOI
Merkliste

15
Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents

von Danielle Hammond ; Sanam Loghavi ; Sa A. Wang ; et al.

Blood Cancer Journal, Vol 13, Iss 1, Pp 1-4 (2023)

Schlagworte: Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

16
A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents

von Nicholas J. Short ; Muharrem Muftuoglu ; Faustine Ong ; et al.

Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-11 (2023)

Schlagworte: Protein neddylation; Elderly; Myeloid diseases; Therapy; Clinical trial; Diseases of the blood and blood-forming organs; RC633-647.5; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

17
A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis

von Jayastu Senapati ; Muharrem Muftuoglu ; Jo Ishizawa ; et al.

Blood Cancer Journal, Vol 13, Iss 1, Pp 1-6 (2023)

Schlagworte: Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

18
Outcomes and genetic dynamics of acute myeloid leukemia at first relapse

von Alex Bataller ; Hagop Kantarjian ; Alexandre Bazinet ; et al.

Haematologica, Vol 999, Iss 1 (2024)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

19

Dieses Ergebnis aus CINAHL kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.

Merkliste

20
Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia

von Aram Bidikian ; Hagop Kantarjian ; Elias Jabbour ; et al.

Blood Cancer Journal, Vol 12, Iss 10, Pp 1-7 (2022)

Schlagworte: Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

21
Cladribine-Based Therapy for Acute Myeloid Leukemia in Child, Adolescent, and Early Young Adult Patients: The MD Anderson Cancer Center Experience

von David McCall ; Shaikha Alqahtani ; Moriah Budak ; et al.

Cancers ; Volume 16 ; Issue 22 ; Pages: 3886

Schlagworte: acute myeloid leukemia; cladribine; purine analog; leukemia; pediatrics; adolescents
- View full text via BASE
Merkliste

22
Revumenib in patients with acute leukemias: compassionate use program experience /

von Rubnitz, Jeffrey ; C. Issa, Ghayas ; M. Stein, Eytan ; et al.

HemaSphere: 28th Congress of the European Hematology Association EHA2023, June 8 - 15, Frankfurt, 2023 : abstract book., Philadelphia : Wolters Kluwer Health, Inc., 2023, vol. 7, suppl. 3, art. no. P561, p. 981-982. ; eISSN 2572-9241

Schlagworte: acute lymphoblastic leukemia; acute leukemia; acute myeloid leukemia; relapsed acute lymphoblastic leukemia
- View full text via BASE
Merkliste

23
Impact of frontline treatment approach on outcomes in patients with secondary AML with prior hypomethylating agent exposure

von Nicholas J. Short ; Sangeetha Venugopal ; Wei Qiao ; et al.

Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-10 (2022)

Schlagworte: Acute myeloid leukemia; Azacitidine; Decitabine; Myelodysplastic syndrome; Chronic myelomonocytic leukemia; Diseases of the blood and blood-forming organs; RC633-647.5; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

24
Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements

von Ghayas C. Issa ; Jabra Zarka ; Koji Sasaki ; et al.

Blood Cancer Journal, Vol 11, Iss 9, Pp 1-10 (2021)

Schlagworte: Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

25
The ChatGPT artificial intelligence chatbot : how well does it answer accounting assessment questions?

von Wood, David A. ; Achhpilia, Muskan P. ; Adams, Mollie T. ; et al.

ISSUES IN ACCOUNTING EDUCATION ; ISSN: 0739-3172 ; ISSN: 1558-7983

Schlagworte: Technology and Engineering; Education; Accounting; crowdsourcing; assessment; accounting education; GPT-3; chat bots; artificial intelligence
- View full text via BASE
Merkliste

12 3 4 5 6 7 8 9 10 11 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag